SCHEMBL6213345

SCHEMBL6213345

CC(O)CNC(CO)(CO)CO

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
RAB9A P51151 1/20 0.34
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21093333 0.88 TDP1 (0.33) TDP1TSHR
SCHEMBL9165305 0.81 TSHR (0.35) RAB9ATSHRALDH1A1
SCHEMBL28121797 0.79 TSHR (0.38) TDP1TSHRALDH1A1
SCHEMBL28410443 0.78 RAB9A (0.36) RAB9A
SCHEMBL115875 0.78 RAB9A (0.43) RAB9AALDH1A1
SCHEMBL9647365 0.77 TDP1 (0.36) TDP1TSHR
SCHEMBL11702665 0.77 TDP1 (0.36) TDP1TSHR
SCHEMBL16359277 0.75
SCHEMBL5838033 0.75
SCHEMBL14660942 0.75 RAB9A (0.39) RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3621735-B1 PROTECTIVE SURFACE COATINGS FOR FLOW CELLS ILLUMINA INC (US) 2024-11-27 EP claimed
EP-3533780-A1 AMINOALCOHOL COMPOUNDS AND THEIR USE AS ZERO OR LOW VOC ADDITIVES FOR PAINTS AND COATINGS ANGUS Chemical Company (US) 2019-09-04 EP claimed
US-9605163-B2 Aminoalcohol compounds and their use as zero or low VOC additives for paints and coatings ANGUS CHEMICAL COMPANY (US) 2017-03-28 US claimed
US-20140130714-A1 AMINOALCOHOL COMPOUNDS AND THEIR USE AS ZERO OR LOW VOC ADDITIVES FOR PAINTS AND COATINGS ANGUS CHEMICAL COMPANY (US) 2014-05-15 US claimed
WO-2013016270-A1 AMINOALCOHOL COMPOUNDS AND THEIR USE AS ZERO OR LOW VOC ADDITIVES FOR PAINTS AND COATINGS ANGUS CHEMICAL COMPANY (US) 2013-01-31 WO claimed
EP-0722492-B1 STABILISATION OF PROTEINS IN SOLUTION UNIV LEEDS INNOVATIONS LTD (GB) 2005-03-09 EP claimed
US-20260002183-A1 ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS EVONIK OPERATIONS GMBH (DE) 2026-01-01 US disclosed
US-20250026818-A1 MALE CONTRACEPTION Sciencemed Spóka z ograniczon odpowiedzialnoci (PL) 2025-01-23 US disclosed
CN-117119892-A Enzymatic process for producing L-glufosinate-ammonium and its phosphate 赢创运营有限公司 2023-11-24 CN disclosed
US-20200215051-A1 NEBULIZATION COMPOSITION COMPRISING TIOTROPIUM AND INDACATEROL GLENMARK SPECIALTY S.A. (CH) 2020-07-09 US disclosed
EP-3533780-A1 AMINOALCOHOL COMPOUNDS AND THEIR USE AS ZERO OR LOW VOC ADDITIVES FOR PAINTS AND COATINGS ANGUS Chemical Company (US) 2019-09-04 EP disclosed
EP-3533780-A1 AMINOALCOHOL COMPOUNDS AND THEIR USE AS ZERO OR LOW VOC ADDITIVES FOR PAINTS AND COATINGS ANGUS Chemical Company (US) 2019-09-04 EP disclosed
US-10314816-B2 Antimicrobial compounds, compositions and methods of use thereof WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-06-11 US disclosed
US-7354517-B2 Separation of platinum group metals ANGLO PLATINUM LIMITED (ZA) 2008-04-08 US disclosed
EP-1596192-A1 Methode for separating proteins by capillary electrophoresis and buffer composition for capillary electrophoresis Sebia (FR) 2005-11-16 EP disclosed
EP-0722492-B1 STABILISATION OF PROTEINS IN SOLUTION UNIV LEEDS INNOVATIONS LTD (GB) 2005-03-09 EP disclosed
EP-1229325-A1 Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis SEBIA (FR) 2002-08-07 EP disclosed
WO-2002057737-A2 METHOD FOR SEPARATING PROTEINS BY CAPILLARY ELECTROPHORESIS AND BUFFER COMPOSITIONS FOR CAPILLARY ELECTROPHORESIS SEBIA (FR) 2002-07-25 WO disclosed
US-6133229-A STABILIZING AQUEOUS ENZYME WITH AQUEOUS SOLUTION COMPRISING TRIS/HYDROXYMETHYL/METHYL COMPOUND, CATIONIC POLYELECTROLYTE, POLYOL, SALT OF CALCIUM, MAGNESIUM AND/OR COBALT THE UNIVERSITY OF LEEDS INNOVATIONS, LTD. (GB) 2000-10-17 US disclosed
EP-0714655-A1 Cosmetic composition and method for suppressing human body malodeur arise from sweat LABORATOIRE DE BIOLOGIE VEGETALE YVES ROCHER (FR) 1996-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10314816-B2 Antimicrobial compounds, compositions and methods of use thereof CLPP, ATP5ME, PCNA TDP1 3579/4885RAB9A 3538/4885TSHR 4853/4885
US-20260002183-A1 ENZYMATIC METHOD FOR PRODUCING L-GLUFOSINATE AND ITS PHOSPHOESTERS PGLS, GLO1, GLUL TDP1 1359/4885RAB9A 4766/4885TSHR 3647/4885
US-20200215051-A1 NEBULIZATION COMPOSITION COMPRISING TIOTROPIUM AND INDACATEROL IL5, IL17A, CFTR TDP1 2237/4885RAB9A 1525/4885TSHR 2284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.